STOCK TITAN

QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2023 RESULTS

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
  • Net sales of $495.4 million in Q2'23, an increase of 1% compared to Q2'22 driven by value-based pricing initiatives
  • Q2'23 net income of $29.3 million and earnings per diluted share of $1.63
  • Q2'23 non-GAAP net income of $34.8 million and non-GAAP earnings per diluted share of $1.93
  • Delivered adjusted EBITDA of $80.2 million in Q2'23, a 37% increase compared to $58.5 million in Q2'22
  • Generated $116.1 million of operating cash flow year-to-date; net debt to adjusted EBITDA improved to 2.3x

CONSHOHOCKEN, Pa., Aug. 1, 2023 /PRNewswire/ -- Quaker Houghton ("the Company") (NYSE: KWR), the global leader in industrial process fluids, announced its second quarter 2023 results today.


Three Months Ended
June 30,


Six Months Ended
June 30,

($ in thousands, except per share data)

2023


2022


2023


2022

Net sales

$           495,444


$           492,388


$         995,592


$         966,559

Net income attributable to Quaker Chemical Corporation

29,346


14,343


58,880


34,159

Net income attributable to Quaker Chemical Corporation
common shareholders – diluted

1.63


0.80


3.27


1.91

Non-GAAP net income *

34,774


23,675


68,766


49,145

Non-GAAP Earnings per diluted share *

1.93


1.32


3.82


2.74

Adjusted EBITDA *

80,242


58,491


159,033


118,935



*

Refer to the Non-GAAP Measures and Reconciliations section below for additional information

Second Quarter 2023 Consolidated Results

Second quarter of 2023 net sales were $495.4 million, an increase of 1% compared to $492.4 million in the second quarter of 2022 primarily due to an increase in selling price and product mix of approximately 11%, partially offset by a 10% decrease in sales volumes.  The increase in selling price and product mix was primarily attributable to increases in selling prices in all segments to offset the significant inflationary pressures on the business.  The decline in sales volumes was primarily attributable to a continuation of softer market conditions and the impact of the war in Ukraine in the EMEA segment. 

The Company reported net income in the second quarter of 2023 of $29.3 million, or $1.63 per diluted share, compared to net income of $14.3 million or $0.80 per diluted share in the second quarter of 2022.  Excluding non-recurring and non-core items in each period, the Company's non-GAAP net income and earnings per diluted share were $34.8 million and $1.93 respectively in the second quarter of 2023 compared to $23.7 million and $1.32 respectively in the prior year.  The Company generated adjusted EBITDA of $80.2 million in the second quarter of 2023, an increase of 37% compared to $58.5 million in the second quarter of 2022, primarily due to an increase in net sales and an improvement in gross margins compared to the prior year.

Andy Tometich, Chief Executive Officer and President, commented, "In the second quarter, Quaker Houghton once again successfully managed through a very challenging operating environment and achieved strong results.  Despite market conditions, we have made meaningful progress improving the profitability of our business through our margin initiatives and delivered double-digit year-over-year earnings growth and solid cash flow.

Looking ahead, we expect the current uneven end market environment will persist at least through the end of the year.  We will continue to execute on what we can control, including investing to strengthen the business, delivering value to customers, advancing our strategic initiatives, and delivering strong year-over-year growth in earnings and cash flow.  I am confident in our strategy and believe these actions best position Quaker Houghton to deliver on our profitable growth potential."

Second Quarter 2023 Segment Results

During the first quarter of 2023, the Company reorganized its executive management team to align with its new business structure. The Company's new structure includes three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific. Prior to the Company's reorganization, the Company's historical reportable segments were: (i) Americas; (ii) EMEA; (iii) Asia/Pacific; and (iv) Global Specialty Businesses. Prior period information has been recast to align with the Company's business structure as of January 1, 2023.

The Company's three and six months of June 30, 2023 operating performance of each of its three reportable segments, (i) Americas; (ii) EMEA; and (iii) Asia/Pacific, are further described below.


Three Months Ended
June 30,


Six Months Ended
June 30,


2023


2022


2023


2022

Net Sales *








Americas

$         253,219


$         235,809


$         504,632


$         447,900

EMEA

143,533


145,535


295,982


292,354

Asia/Pacific

98,692


111,044


194,978


226,305

Total net sales

$         495,444


$         492,388


$         995,592


$         966,559

Segment operating earnings *








Americas

$           69,007


$           52,137


$         135,132


$           97,316

EMEA

25,583


20,076


53,154


43,324

Asia/Pacific

27,989


24,922


55,641


49,423

Total segment operating earnings

$         122,579


$           97,135


$         243,927


$         190,063



*

Refer to the Segment Measures and Reconciliations section below for additional information

Net sales in the Americas segment increased in the second quarter of 2023 compared to the same period in 2022 primarily due to an increase in selling price and product mix, partially offset by a decline in sales volumes.  Net sales in the EMEA segment were similarly a result of an increase in selling price and product mix and a favorable impact from foreign currency translation, offset by a decline in sales volumes.  Net sales in the Asia/Pacific segment declined compared to the prior year quarter as a decline in sales volumes and a headwind from foreign currency translation more than offset an increase in selling price and product mix.  The increase in selling price and product mix was primarily related to our value-based pricing initiatives implemented across all segments.  The decline in sales volumes was similar across all segments and primarily reflects softer market conditions and the impact of the ongoing war in Ukraine in the EMEA segment.

Compared to the first quarter of 2023, net sales increased in the Americas and Asia/Pacific segments but declined in the EMEA segment.  Sales volumes in the Asia/Pacific segment increased, remained stable in the Americas and declined in EMEA.  Selling price and product mix was consistent with the prior quarter in all segments.

Operating earnings increased in all three segments in the second quarter of 2023 compared to the prior year, primarily driven by an improvement in operating margins in all segments.  Operating margins increased in the Americas segment and were similar in the Asia/Pacific and EMEA segments in the second quarter compared to the first quarter of 2023.

Cash Flow and Liquidity Highlights

Net cash provided by operating activities was $116.1 million for the first six months of 2023 compared to net cash used in operating activities of $8.4 million in the first six months of 2022. The improvement in net operating cash flow primarily reflects a stronger operating performance and working capital management in the first six months of 2023 compared to the same period in 2022.

As of June 30, 2023, the Company's total gross debt was $885.1 million, and its cash and cash equivalents was $189.4 million, which resulted in net debt of approximately $695.7 million.  The Company's net debt divided by its trailing twelve months adjusted EBITDA was approximately 2.3x.

Non-GAAP Measures and Reconciliations

The information included in this press release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share.  The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are indicative of future operating performance of the Company, and facilitate a comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered indicative of future operating performance or not considered core to the Company's operations.  Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. In addition, our definitions of EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share, as discussed and reconciled below to the most comparable respective GAAP measures, may not be comparable to similarly named measures reported by other companies

The Company presents EBITDA which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies.  The Company also presents adjusted EBITDA which is calculated as EBITDA plus or minus certain items that are not considered indicative of future operating performance or not considered core to the Company's operations. In addition, the Company presents non-GAAP operating income which is calculated as operating income plus or minus certain items that are not considered indicative of future operating performance or not considered core to the Company's operations. Adjusted EBITDA margin and non-GAAP operating margin are calculated as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.

Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures.  Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA.  Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the "two-class share method." The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.

As it relates to future projections for the Company as well as other forward-looking information described further above, the Company has not provided guidance for comparable GAAP measures or a quantitative reconciliation of forward-looking non-GAAP financial measures to the most directly comparable U.S. GAAP measure because it is unable to determine with reasonable certainty the ultimate outcome of certain significant items necessary to calculate such measures without unreasonable effort.  These items include, but are not limited to, certain non-recurring or non-core items the Company may record that could materially impact net income, as well as the impact of COVID-19.  These items are uncertain, depend on various factors, and could have a material impact on the U.S. GAAP reported results for the guidance period.

The Company's reference to trailing twelve months adjusted EBITDA within this press release refers to the twelve month period ended June 30, 2023 adjusted EBITDA of $297.2 million, which includes (i) the six months ended June 30, 2023 adjusted EBITDA of $159.0 million, as presented in the non-GAAP reconciliations below, and (ii) the twelve months ended December 31, 2022 adjusted EBITDA of $257.2 million, as presented in the non-GAAP reconciliations included in the Company's fourth quarter and full year 2022 results press release dated February 23, 2023, less (iii) the six months ended June 30, 2022 adjusted EBITDA of $118.9 million, as presented in the non-GAAP reconciliations below.

Certain of the prior period non-GAAP financial measures presented in the following tables have been adjusted to conform with current period presentation.  The following tables reconcile the Company's non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts):


Three Months Ended
June 30,


Six Months Ended
June 30,

Non-GAAP Operating Income and Margin Reconciliations:

2023


2022


2023


2022

Operating income

$         56,795


$         31,903


$       106,724


$         61,306

Combination, integration and other acquisition-related expenses (a)


1,831



5,885

Restructuring and related charges (credits), net

1,043


(1)


5,015


819

Strategic planning expenses

579


3,112


2,666


6,200

Russia-Ukraine conflict related expenses


929



2,095

Other charges

344


1,031


649


1,660

Non-GAAP operating income

$         58,761


$         38,805


$       115,054


$         77,965

Non-GAAP operating margin (%)

11.9 %


7.9 %


11.6 %


8.1 %

 

EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and
Non-GAAP Net Income Reconciliations:

Three Months Ended
June 30,


Six Months Ended
June 30,

2023


2022


2023


2022

Net income attributable to Quaker Chemical Corporation

$         29,346


$         14,343


$         58,880


$         34,159

Depreciation and amortization (b)

20,834


20,856


41,344


41,583

Interest expense, net

12,721


6,494


25,963


11,839

Taxes on income before equity in net income of associated
companies (c)

13,830


1,374


23,363


4,240

EBITDA

76,731


43,067


149,550


91,821

Equity loss in a captive insurance company

430


1,781


8


2,025

Combination, integration and other acquisition-related (credits)
expenses (a)

(475)


2,248


(475)


8,281

Restructuring and related charges (credits), net

1,043


(1)


5,015


819

Strategic planning expenses

579


3,112


2,666


6,200

Russia-Ukraine conflict related expenses


929



2,095

Currency conversion impacts of hyper-inflationary economies

1,184


36


1,640


224

Loss on extinguishment of debt


6,763



6,763

Other charges

750


556


629


707

Adjusted EBITDA

$         80,242


$         58,491


$       159,033


$       118,935

Adjusted EBITDA margin (%)

16.2 %


11.9 %


16.0 %


12.3 %









Adjusted EBITDA

$         80,242


$         58,491


$       159,033


$       118,935

Less: Depreciation and amortization - adjusted (b)

20,834


20,856


41,344


41,583

Less: Interest expense, net

12,721


6,494


25,963


11,839

Less: Taxes on income before equity in net income of associated
companies - adjusted (c)

11,913


7,466


22,960


16,368

Non-GAAP net income

$         34,774


$         23,675


$         68,766


$         49,145





Three Months Ended
June 30,


Six Months Ended
June 30,

Non-GAAP Earnings per Diluted Share Reconciliations:

2023


2022


2023


2022

GAAP earnings per diluted share attributable to Quaker Chemical
Corporation common shareholders

$                1.63


$                0.80


$                3.27


$                1.91

Equity loss in a captive insurance company per diluted share

0.02


0.10


0.00


0.11

Combination, integration and other acquisition-related (credits)
expenses per diluted share (a)

(0.03)


0.13


(0.03)


0.38

Restructuring and related charges (credits), net per diluted share

0.04


(0.00)


0.21


0.03

Strategic planning expenses per diluted share

0.03


0.13


0.13


0.27

Russia-Ukraine conflict related expenses per diluted share


0.04



0.10

Currency conversion impacts of hyper-inflationary economies
per diluted share

0.06


0.00


0.09


0.01

Loss on extinguishment of debt per diluted share


0.29



0.29

Other charges per diluted share

0.04


0.03


0.02


0.03

Impact of certain discrete tax items per diluted share

0.14


(0.20)


0.13


(0.39)

Non-GAAP earnings per diluted share

$                1.93


$                1.32


$                3.82


$                2.74



(a)   

Combination, integration and other acquisition-related (credits) expenses in 2022 included certain legal, financial, and other advisory and consultant costs incurred in connection with the Combination integration activities. These amounts also include expense associated with the Company's other recent acquisitions, including certain legal, financial, and other advisory and consultant costs incurred in connection with due diligence.  During both the three and six months ended June 30, 2023, the Company recorded $0.5 million of other income due to changes in an indemnification asset related to the Combination. Similarly, during the three and six months ended June 30, 2022, the Company recorded expenses of $0.4 million and $2.4 million, respectively, of other expenses due to changes in a Combination-related indemnification asset.  These amounts were recorded within Other expense, net and therefore are included in the caption "Combination, integration and other acquisition-related (credits) expenses" in the reconciliation of Net income attributable to Quaker Chemical Corporation to Adjusted EBITDA and GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders to Non-GAAP earnings per diluted share, however it is excluded in the reconciliation of Operating income to Non-GAAP operating income.



(b)   

Depreciation and amortization for the three and six months ended June 30, 2023 and the same period of 2022 includes approximately $0.2 million and $0.5 million, respectively, of amortization expense recorded within equity in net income of associated companies in the Condensed Consolidated Statement of Income, which is attributable to the amortization of the fair value step up for the Company's 50% interest in a joint venture in Korea as a result of required purchase accounting.



(c)

Taxes on income before equity in net income of associated companies – adjusted includes the Company's tax expense adjusted for the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of Net income attributable to Quaker Chemical Corporation to adjusted EBITDA, above, determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility. This caption also includes the impact of specific tax charges and benefits in the three and six months ended June 30, 2023 and 2022, which the Company does not consider core to the Company's operations or indicative of future performance.

Segment Measures and Reconciliations

Segment operating earnings for each of the Company's reportable segments are comprised of the segment's net sales less directly related Cost of goods sold ("COGS") and Selling, general and administrative expenses ("SG&A"). Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs, Combination, integration and other acquisition-related expenses, and Restructuring and related charges (credits), net, are not included in segment operating earnings. Other items not specifically identified with the Company's reportable segments include Interest expense, net and Other expense, net.

The following table presents information about the performance of the Company's reportable segments (dollars in thousands):


Three Months Ended
June 30,


Six Months Ended
June 30,


2023


2022


2023


2022

Net Sales








Americas

$         253,219


$         235,809


$         504,632


$         447,900

EMEA

143,533


145,535


295,982


$         292,354

Asia/Pacific

98,692


111,044


194,978


$         226,305

Total net sales

$         495,444


$         492,388


$         995,592


$         966,559

Segment operating earnings








Americas

$           69,007


$           52,137


$         135,132


$           97,316

EMEA

25,583


20,076


53,154


$           43,324

Asia/Pacific

27,989


24,922


55,641


$           49,423

Total segment operating earnings

122,579


97,135


243,927


190,063

Combination, integration and other acquisition-related expenses


(1,832)



(5,885)

Restructuring and related (charges) credits, net

(1,043)


1


(5,015)


(819)

Non-operating and administrative expenses

(49,950)


(48,579)


(101,721)


(92,042)

Depreciation of corporate assets and amortization

(14,791)


(14,822)


(30,467)


(30,011)

Operating income

56,795


31,903


106,724


61,306

Other expense, net

(3,606)


(8,399)


(5,845)


(10,605)

Interest expense, net

(12,721)


(6,494)


(25,963)


(11,839)

Income before taxes and equity in net income of associated
companies

$           40,468


$           17,010


$           74,916


$           38,862

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements can be identified by the fact that they do not relate strictly to historical or current facts.  We have based these forward-looking statements on our current expectations about future events, including statements regarding the potential effects of the COVID-19 pandemic, the Russia and Ukraine conflict, inflation, bank failures, higher interest rate environment, global supply chain constraints on the Company's business, results of operations, and financial condition, our expectations that we will maintain sufficient liquidity, remain in compliance with the terms of the Company's credit facility,  expectation about future demand and raw material costs, and statements regarding the impact of increased raw material costs and pricing initiatives.  These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance, and business, including but not limited to the potential benefits of the Combination and other acquisitions, the impacts on our business as a result of the COVID-19 pandemic and global supply chain constraints, and our current and future results and plans and statements that include the words "may," "could," "should," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan" or similar expressions.  These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements.  A major risk is that demand for the Company's products and services is largely derived from the demand for its customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production slowdowns and shutdowns, including as is currently being experienced by many automotive industry companies as a result of supply chain disruptions.  Other major risks and uncertainties include, but are not limited to, the primary and secondary impacts of the COVID-19 pandemic, including actions taken in response to the pandemic by various governments, which could exacerbate some or all of the other risks and uncertainties faced by the Company, as well as inflationary pressures, including the potential for significant increases in raw material costs, supply chain disruptions, customer financial instability, rising interest rates and the potential of economic recession, worldwide economic and political disruptions, including the impacts of the military conflict between Russia and Ukraine, the economic and other sanctions imposed by other nations on Russia, suspensions of activities in Russia by many multinational companies and the potential expansion of military activity, foreign currency fluctuations, significant changes in applicable tax rates and regulations, future terrorist attacks and other acts of violence. Furthermore, the Company is subject to the same business cycles as those experienced by our customers in the steel, automobile, aircraft, industrial equipment, and durable goods industries.  Our forward-looking statements are subject to risks, uncertainties and assumptions about the Company and its operations that are subject to change based on various important factors, some of which are beyond our control.  These risks, uncertainties, and possible inaccurate assumptions relevant to our business could cause our actual results to differ materially from expected and historical results.  All forward-looking statements included in this press release, including expectations about business conditions during 2023 and future periods, are based upon information available to the Company as of the date of this press release, which may change.  Therefore, we caution you not to place undue reliance on our forward-looking statements.  For more information regarding these risks and uncertainties as well as certain additional risks that we face, refer to the Risk Factors section, which appears in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022, and in subsequent reports filed from time to time with the Securities and Exchange Commission.  We do not intend to, and we disclaim any duty or obligation to, update or revise any forward-looking statements to reflect new information or future events or for any other reason.  This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

Conference Call

As previously announced, the Company's investor conference call to discuss its second quarter of 2023 performance is scheduled for Wednesday, August 2, 2023 at 8:30 a.m. ET. A live webcast of the conference call, together with supplemental information, can be accessed through the Company's Investor Relations website at investors.quakerhoughton.com. You can also access the conference call by dialing 877-269-7756.

About Quaker Houghton

Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, our customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies.  Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge and customized services.  With approximately 4,600 employees, including chemists, engineers and industry experts, we partner with our customers to improve their operations so they can run even more efficiently, even more effectively, whatever comes next.  Quaker Houghton is headquartered in Conshohocken, Pennsylvania, located near Philadelphia in the United States. Visit quakerhoughton.com to learn more.

Quaker Chemical Corporation
Condensed Consolidated Statements of Operations
(Unaudited; Dollars in thousands, except per share data)



Three Months Ended
June 30,


Six Months Ended
June 30,


2023


2022


2023


2022

Net sales

$         495,444


$         492,388


$         995,592


$         966,559

Cost of goods sold

317,753


342,824


644,451


670,924

Gross profit

177,691


149,564


351,141


295,635

Selling, general and administrative expenses

119,853


115,830


239,402


227,625

Restructuring and related charges (credits), net

1,043


(1)


5,015


819

Combination, integration and other acquisition-related expenses


1,832



5,885

Operating income

56,795


31,903


106,724


61,306

Other expense, net

(3,606)


(8,399)


(5,845)


(10,605)

Interest expense, net

(12,721)


(6,494)


(25,963)


(11,839)

Income before taxes and equity in net income of associated
companies

40,468


17,010


74,916


38,862

Taxes on income before equity in net income of associated
companies

13,830


1,374


23,363


4,240

Income before equity in net income of associated companies

26,638


15,636


51,553


34,622

Equity in net income of associated companies

2,755


(1,265)


7,381


(430)

Net income

29,393


14,371


58,934


34,192

Less: Net income attributable to noncontrolling interest

47


28


54


33

Net  income attributable to Quaker Chemical Corporation

$           29,346


$           14,343


$           58,880


$           34,159

Per share data:








Net income attributable to Quaker Chemical Corporation
common shareholders – basic

$                1.63


$                0.80


$                3.28


$                1.91

Net income attributable to Quaker Chemical Corporation
common shareholders – diluted

$                1.63


$                0.80


$                3.27


$                1.91

Basic weighted average common shares outstanding

17,892,444


17,834,329


17,879,629


17,830,218

Diluted weighted average common shares outstanding

17,921,414


17,841,377


17,909,906


17,847,404

 

Quaker Chemical Corporation
Condensed Consolidated Balance Sheets
(Unaudited; Dollars in thousands, except par value)



June 30,
2023


December 31,
2022

ASSETS




Current assets




Cash and cash equivalents

$         189,405


$         180,963

Accounts receivable, net

454,230


472,888

Inventories, net

274,940


284,848

Prepaid expenses and other current assets

65,426


55,438

Total current assets

984,001


994,137





Property, plant and equipment, net

204,732


198,595

Right of use lease assets

40,983


43,766

Goodwill

507,370


515,008

Other intangible assets, net

918,143


942,925

Investments in associated companies

91,960


88,234

Deferred tax assets

10,033


11,218

Other non-current assets

33,019


27,739

Total assets

$      2,790,241


$      2,821,622





LIABILITIES AND EQUITY




Current liabilities




Short-term borrowings and current portion of long-term debt

$           19,369


$           19,245

Accounts payable

193,790


193,983

Dividends payable

7,830


7,808

Accrued compensation

35,129


39,834

Accrued restructuring

5,160


5,483

Accrued pension and postretirement benefits

1,579


1,560

Other accrued liabilities

83,681


86,873

Total current liabilities

346,538


354,786





Long-term debt

863,934


933,561

Long-term lease liabilities

24,218


26,967

Deferred tax liabilities

156,247


160,294

Non-current accrued pension and postretirement benefits

29,174


28,765

Other non-current liabilities

33,464


38,664

Total liabilities

1,453,575


1,543,037





Equity




Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding June 30, 2023
– 17,999,223 shares; December 31, 2022 – 17,950,264 shares

17,999


17,950

Capital in excess of par value

934,941


928,288

Retained earnings

513,148


469,920

Accumulated other comprehensive loss

(130,108)


(138,240)

Total Quaker shareholders' equity

1,335,980


1,277,918

Noncontrolling interest

686


667

Total equity

1,336,666


1,278,585

Total liabilities and equity

$      2,790,241


$      2,821,622

 

Quaker Chemical Corporation
Condensed Consolidated Statements of Cash Flows
(Unaudited; Dollars in thousands)



Six Months Ended
June 30,


2023


2022

Cash flows from operating activities




Net income

$           58,934


$           34,192

Adjustments to reconcile net income to net cash used in operating activities:




Amortization of debt issuance costs

706


2,236

Depreciation and amortization

40,824


41,036

Equity in undistributed earnings of associated companies, net of dividends

(4,207)


3,400

Deferred compensation, deferred taxes and other, net

154


(10,223)

Share-based compensation

7,414


5,433

Loss on extinguishment of debt


5,246

Loss (gain) on disposal of property, plant, equipment and other assets


15

Combination and other acquisition-related expenses, net of payments


(3,880)

Restructuring and related charges, net

5,015


819

Pension and other postretirement benefits

(308)


(2,269)

Increase (decrease) in cash from changes in current assets and current liabilities, net of
acquisitions:




Accounts receivable

22,017


(51,944)

Inventories

11,750


(58,427)

Prepaid expenses and other current assets

(8,925)


(5,558)

Change in restructuring liabilities

(5,410)


(797)

Accounts payable and accrued liabilities

(11,912)


32,298

Net cash  provided by (used in) operating activities

116,052


(8,423)

Cash flows from investing activities




Investments in property, plant and equipment

(17,040)


(15,138)

Payments related to acquisitions, net of cash acquired


(9,383)

Proceeds from disposition of assets


85

Net cash used in investing activities

(17,040)


(24,436)

Cash flows from financing activities




Payments of long-term debt

(9,439)


(668,500)

Proceeds from long-term debt


750,000

(Payments) borrowings on revolving credit facilities, net

(62,778)


16,703

Payments on other debt, net

(456)


(155)

Financing-related debt issuance costs


(3,734)

Dividends paid

(15,631)


(14,862)

Other stock related activity

(712)


(821)

Net cash (used in) provided by financing activities

(89,016)


78,631

Effect of foreign exchange rate changes on cash

(1,554)


(8,600)

Net decrease in cash and cash equivalents

8,442


37,172

Cash and cash equivalents at the beginning of the period

180,963


165,176

Cash and cash equivalents at the end of the period

$         189,405


$         202,348

 

(PRNewsfoto/Quaker Houghton)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quaker-houghton-announces-second-quarter-2023-results-301890747.html

SOURCE Quaker Houghton

Quaker Houghton

NYSE:KWR

KWR Rankings

KWR Latest News

KWR Stock Data

2.86B
17.99M
23.42%
82.49%
7.13%
Specialty Chemicals
Miscellaneous Products of Petroleum & Coal
Link
United States of America
CONSHOHOCKEN